CORE LABORATORY
Log In
Don't have an account? Sign Up
Home   >     Scientific education   >     Case studies by cell type   >     Red blood cell disorders   >     Anemia   >     Microcytic anemia   >     Iron deficiency anemia after therapy

CELL-DYN Ruby

IRON DEFICIENCY ANEMIA AFTER THERAPY

Description

After diagnosed with a classical iron deficiency, the patient from Iron Deficiency Case received oral iron supplementation therapy. Due to the newly produced normocytic RBC’s the RBC histogram became bimodal (Case A) and the RDW increased from 12.8% to 28.8%. After 3 weeks of therapy patient still had anemia but it is clear that she responded well to iron therapy.

 

After 5 weeks of therapy (Case B) the bimodal RBC histogram was even more distinct indicating that it is only a matter of time before all RBC’s will be normocytic again.

Numerical Results

 
CASE A CASE B
WBC 6.95 10e3/μL 9.13 10e3/μL
NEU 3.402 53.158 % 4.633 50.805 %
BLST 0.02 .033 %  0.01 .012 %
MONe .439 6.87 % .657 7.20 %
EOS .301 4.71 %  1.08 11.8 %
BASO .110 1.72 % .070 .772 %
LYMe 2.145 33.461 % 2.685 29.39 %
 
RBC 4.72 10e6/μL  4.82 10e6/μL
HGB 11.0 g/dL  12.1 g/dL
HCT 36.5 % 39.3 %
MCV 77.4 fL RBC MORPH  81.5 fL RBC MORPH
MCH 23.3 pg  25.5 pg
MCHC 30.1 g/dL  30.9 g/dL
RDW 28. %  26.0 %
 
PLT 402. 10e3/μL 323. 10e3/μL
MPV 7.18 fL 6.87 fL
 
CASE A:
Results after 3 weeks of therapy
CASE B:
Results after 5 weeks of therapy
CELL-DYN Ruby Casebook. Iron Deficiency Anemia After Therapy. 2018. ADD-00005070. p.32
©2021 Abbott, Abbott Park, Illinois, U.S.A.

Privacy Policy| Terms and Conditions

Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.

All Alinity hq, CELL-DYN Ruby and CELL-DYN Sapphire instruments are Class I laser products. ACCELERATOR a3600 is a Class II laser product. 

The Alinity, ACCELERATOR and CELL-DYN systems are intended for performing in vitro diagnostic assays on samples of human origin (blood, urine). Read the instructions in the system manuals and labeling and/or reagent instructions carefully. Manufacturer or Authorized Representative: Abbott Germany.

Alinity h-series is available in select countries, not including the US.